Current Oncology | Top 10 Most Cited Papers in 2023

As Current Oncology (ISSN: 1718-7729) has an open access format, you have free and unlimited access to the full text of all articles published in our journal. We welcome you to read our 2023 top cited papers listed below:

1. “Drug Repurposing in Non-Small Cell Lung Carcinoma: Old Solutions for New Problems”
by George Doumat, Darine Daher, Morgan Bou Zerdan, Nasri Nasra, Hisham F. Bahmad, Monica Recine and Robert Poppiti
Curr. Oncol. 2023, 30(1), 704-719; https://doi.org/10.3390/curroncol30010055
Available online: https://www.mdpi.com/1718-7729/30/1/55

2. “Underlying Features of Prostate Cancer—Statistics, Risk Factors, and Emerging Methods for Its Diagnosis”
by Cristina V. Berenguer, Ferdinando Pereira, José S. Câmara and Jorge A. M. Pereira
Curr. Oncol. 2023, 30(2), 2300-2321; https://doi.org/10.3390/curroncol30020178
Available online: https://www.mdpi.com/1718-7729/30/2/178

3. “Current Overview of Treatment for Metastatic Bone Disease”
by Mohammed Badwelan, Hasan Muaddi, Abeer Ahmed, Kyungjun T. Lee and Simon D. Tran
Curr. Oncol. 2023, 30(4), 3721-3734; https://doi.org/10.3390/curroncol30040283
Available online: https://www.mdpi.com/1718-7729/30/4/283

4. “Machine Learning Approaches with Textural Features to Calculate Breast Density on Mammography”
by Mario Sansone, Roberta Fusco, Francesca Grassi, Gianluca Gatta, Maria Paola Belfiore, Francesca Angelone, Carlo Ricciardi, Alfonso Maria Ponsiglione, Francesco Amato, Roberta Galdiero et al.
Curr. Oncol. 2023, 30(1), 839-853; https://doi.org/10.3390/curroncol30010064
Available online: https://www.mdpi.com/1718-7729/30/1/64

5. “Initial Experiences of Selective RET Inhibitor Selpercatinib in Adults with Metastatic Differentiated Thyroid Carcinoma and Medullary Thyroid Carcinoma: Real-World Case Series in Korea”
by Han-Sang Baek, Jeonghoon Ha, Seunggyun Ha, Ja Seong Bae, Chan Kwon Jung and Dong-Jun Lim
Curr. Oncol. 2023, 30(3), 3020-3031; https://doi.org/10.3390/curroncol30030229
Available online: https://www.mdpi.com/1718-7729/30/3/229

6. “Harnessing Real-World Evidence to Advance Cancer Research”
by Monica Tang, Sallie-Anne Pearson, Robert J. Simes and Boon H. Chua
Curr. Oncol. 2023, 30(2), 1844-1859; https://doi.org/10.3390/curroncol30020143
Available online: https://www.mdpi.com/1718-7729/30/2/143

7. “Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers”
by Marco Russano, Giulia La Cava, Alessio Cortellini, Fabrizio Citarella, Alessandro Galletti, Giuseppina Rita Di Fazio, Valentina Santo, Leonardo Brunetti, Alessia Vendittelli, Iacopo Fioroni et al.
Curr. Oncol. 2023, 30(2), 2366-2387; https://doi.org/10.3390/curroncol30020181
Available online: https://www.mdpi.com/1718-7729/30/2/181

8. “Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients”
by Roberta Rosso, Marta D’Alonzo, Valentina Elisabetta Bounous, Silvia Actis, Isabella Cipullo, Elena Salerno and Nicoletta Biglia
Curr. Oncol. 2023, 30(2), 1461-1472; https://doi.org/10.3390/curroncol30020112
Available online: https://www.mdpi.com/1718-7729/30/2/112

9. “The Effects of Lack of Awareness in Age-Related Quality of Life, Coping with Stress, and Depression among Patients with Malignant Melanoma”
by Ana-Olivia Toma, Estera Boeriu, Luminita Decean, Vlad Bloanca, Felix Bratosin, Mihaela Codrina Levai, Neeharika Gayatri Vasamsetti, Satish Alambaram, Andrada Licinia Oprisoni, Bogdan Miutescu et al.
Curr. Oncol. 2023, 30(2), 1516-1528; https://doi.org/10.3390/curroncol30020116
Available online: https://www.mdpi.com/1718-7729/30/2/116

10. “Artificial Intelligence for Cancer Detection—A Bibliometric Analysis and Avenues for Future Research”
by Erik Karger and Marko Kureljusic
Curr. Oncol. 2023, 30(2), 1626-1647; https://doi.org/10.3390/curroncol30020125
Available online: https://www.mdpi.com/1718-7729/30/2/125